ZIMV zimvie.com: Company Value to Revenue

Official company branding of ZimVie (ZIMV)

The price-to-sales multiple for ZimVie Inc. (ZIMV) on GURU.Markets reflects current price action, where the indicator is fixed at . The business is stabilizing by divesting certain assets to reduce debt. Profitability is now based on B2B supplies of dental systems and plant efficiency. Stability is guaranteed by unique pediatric spinal correction methods and the status of the products as vital medical devices.

zimvie.com (ZIMV): Enterprise Value-to-Revenue Ratio from 07/04/2022 to 11/20/2026

ZIMV (ZimVie Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental valuation:ZimVie Inc.
Manufactured products of ZimVie Dental

When stress-testing assets, it is essential to evaluate business value through the lens of operational efficiency. For ZimVie Inc. (ZIMV), expansion rates in spinal surgery and competitive pressure are critical. By analyzing the EV-to-revenue multiple, an investor can determine the ratio of the company's total enterprise value to its sales, excluding the impact of debt load. The stabilization of this metric signals the formation of a sustainable trend, allowing for the identification of risks regarding overpayment or business undervaluation.

Competitor analysis for ZimVie Inc.

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple